Lista de obras -

193TiP: CheckMate 171: A multicenter phase 2 trial of nivolumab (nivo) in patients (pts) with stage IIIB/IV squamous cell (SQ) NSCLC who have received ≥1 prior systemic treatment

A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03) ⬇️

artículo científico publicado el 28 de julio de 2011

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer

artículo científico publicado en 2010

A rare cause of haemoptysis

artículo científico publicado en 2014

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

artículo científico publicado en 2015

Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks

artículo científico publicado en 2018

Are EUS–FNA and EBUS–TBNA specimens reliable for subtyping non-small cell lung cancer? ⬇️

artículo científico publicado el 25 de septiembre de 2011

BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer

artículo científico publicado en 2013

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

scientific article published on 17 July 2019

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials

artículo científico publicado en 2008

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial ⬇️

artículo científico publicado en 2017

Continuous professional development: elevating thoracic oncology education in Europe

artículo científico publicado en 2019

Defining a standard set of patient-centred outcomes for lung cancer

artículo científico publicado en 2016

Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS).

artículo científico publicado en 2016

Effects of Whole Body Vibration in Patients With COPD.

artículo científico publicado en 2015

Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer

artículo científico publicado en 2010

Estimation of post-operative forced expiratory volume by functional respiratory imaging.

artículo científico publicado en 2014

Exhaled breath to screen for malignant pleural mesothelioma: a validation study.

artículo científico publicado en 2017

Facts, rumours and speculations about the mesothelioma epidemic ⬇️

artículo científico publicado el 1 de octubre de 2011

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

artículo científico publicado en 2009

Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials

artículo científico publicado en 2011

Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials

artículo científico

Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.

artículo científico

Investigational Approaches for Mesothelioma ⬇️

artículo científico publicado el 22 de agosto de 2011

Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy

artículo científico publicado en 2020

Lung cancer staging: imagine fewer images

artículo científico publicado en 2018

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

artículo científico publicado en 2019

Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period.

artículo científico publicado en 2017

Malignant pleural mesothelioma: when is radiation therapy indicated? ⬇️

artículo científico publicado el 1 de abril de 2011

Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption ⬇️

artículo científico publicado el 2 de marzo de 2012

Molecular profiling in lung cancer associated with cystic airspaces

artículo científico publicado en 2019

Multimodal management of malignant pleural mesothelioma: where are we today?

artículo científico publicado en 2014

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

scientific article published on 15 May 2019

Novel treatment options in stage I non-small-cell lung cancer

artículo científico publicado en 2014

Pleural Nodules and Mediastinal Lymphadenopathy in a Smoker: An Unusual Case Report

artículo científico publicado en 2016

Practical tools for implementing early palliative care in advanced lung cancer

artículo científico publicado en 2016

Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country ⬇️

artículo científico publicado el 23 de julio de 2011

Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma

artículo científico publicado en 2016

Raltitrexed in mesothelioma ⬇️

artículo científico publicado el 1 de octubre de 2011

Reply to K. Masuda et al

scientific article published on 22 July 2019

Routine implementation of EGFR mutation testing in clinical practice in Flanders: 'HERMES' project

artículo científico publicado en 2014

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis

artículo científico publicado en 2012

Small-cell lung cancer

artículo científico publicado en 2011

Small-cell lung cancer: local therapy for a systemic disease?

artículo científico publicado en 2014

Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma ⬇️

artículo científico publicado el 1 de noviembre de 2011

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

scientific article published on 01 February 2020

Spirometric reference values for an East-African population

artículo científico publicado en 2012

Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis

artículo científico publicado en 2014

Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.

artículo científico publicado en 2014

Surgery in Mesothelioma – Where Do We Go after MARS? ⬇️

artículo científico publicado el 1 de mayo de 2013

Surgery or radiotherapy for early-stage lung cancer--a potential comparison bias.

artículo científico publicado en 2013

Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pl

artículo científico publicado en 2007

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

article

The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation

artículo científico publicado en 2016

The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma

artículo científico publicado en 2016

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors

artículo científico publicado en 2014

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors

artículo científico publicado en 2014

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors

artículo científico publicado en 2014

The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors

artículo científico publicado en 2014

The controversial role of surgery in stage III NSCLC

artículo científico publicado en 2008

The sound of the parasite. Diagnosing mediastinal cysts with endoscopic ultrasound techniques

artículo científico publicado en 2005

Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma

artículo científico publicado en 2008

Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future

Treatment of extensive-stage small cell lung carcinoma: current status and future prospects

artículo científico publicado en 2010

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

artículo científico publicado en 2010

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial

artículo científico publicado en 2019

What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?

artículo científico publicado en 2008

Lista de obras de

193TiP: CheckMate 171: A multicenter phase 2 trial of nivolumab (nivo) in patients (pts) with stage IIIB/IV squamous cell (SQ) NSCLC who have received ≥1 prior systemic treatment

A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03) ⬇️

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer

A rare cause of haemoptysis

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks

Are EUS–FNA and EBUS–TBNA specimens reliable for subtyping non-small cell lung cancer? ⬇️

BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial ⬇️

Continuous professional development: elevating thoracic oncology education in Europe

Defining a standard set of patient-centred outcomes for lung cancer

Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS).

Effects of Whole Body Vibration in Patients With COPD.

Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer

Estimation of post-operative forced expiratory volume by functional respiratory imaging.

Exhaled breath to screen for malignant pleural mesothelioma: a validation study.

Facts, rumours and speculations about the mesothelioma epidemic ⬇️

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials

Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials

Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.

Investigational Approaches for Mesothelioma ⬇️

Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy

Lung cancer staging: imagine fewer images

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period.

Malignant pleural mesothelioma: when is radiation therapy indicated? ⬇️

Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption ⬇️

Molecular profiling in lung cancer associated with cystic airspaces

Multimodal management of malignant pleural mesothelioma: where are we today?

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Novel treatment options in stage I non-small-cell lung cancer

Pleural Nodules and Mediastinal Lymphadenopathy in a Smoker: An Unusual Case Report

Practical tools for implementing early palliative care in advanced lung cancer

Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country ⬇️

Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma

Raltitrexed in mesothelioma ⬇️

Reply to K. Masuda et al

Routine implementation of EGFR mutation testing in clinical practice in Flanders: 'HERMES' project

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis

Small-cell lung cancer

Small-cell lung cancer: local therapy for a systemic disease?

Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma ⬇️

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

Spirometric reference values for an East-African population

Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis

Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.

Surgery in Mesothelioma – Where Do We Go after MARS? ⬇️

Surgery or radiotherapy for early-stage lung cancer--a potential comparison bias.

Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pl

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation

The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors

The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors

The controversial role of surgery in stage III NSCLC

The sound of the parasite. Diagnosing mediastinal cysts with endoscopic ultrasound techniques

Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma

Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future

Treatment of extensive-stage small cell lung carcinoma: current status and future prospects

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial

What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?